Study S000844

Effect of the Weekly Administration of Exenatide LAR or Dulaglutide on the Variability of Blood Pressure and Heart Rate of 24 Hours in Patients With Type 2 Diabetes Mellitus Without Pharmacological Treatment.

ClinicalTrials.gov record

Registration

Registration: NCT03444142
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 30
Start: 2017-11-17
Primary completion: 2021-11-30
Lead sponsor: University of Guadalajara
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Exenatide LAR; DRUG:Dulaglutide
Results posted: FALSE

Registered primary outcomes

Heart rate: nighttime, daytime and 24-h [Baseline to Week 4]
Systolic blood pressure, daytime, night and 24 h [Baseline to Week 4]
Diastolic blood pressure, daytime, night and 24 h [Baseline to Week 4]
Blood pressure [Baseline to Week 4]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.